Anti-LIMK1(L04-63R)

Anti-LIMK1(L04-63R)

  • $369.00


FOR BULK ORDER REQUESTS PLEASE CONTACT US

Description :Rabbit Polyclonal Antibody

Species :

Tag :

Expression System:

Sequence :

Specificity :Recognizes the human LIM Kinase protein

Cited Applications :ELISA, IF, WB
Ideal working dilutions for each application should be empirically determined by the investigator

Cross Reactivity :Human

Host Isotype / Clone# :Rabbit, IgG

Immunogen :The antibody was produced against synthesized peptide corresponding to amino acids 630-647 of human LIM Kinase protein.

Purification :Immunoaffinity chromatography

Stability :1yr at –20oC from date of shipment

Sample Data :Western blot using Anti-LIMK1 (1:500 dilution) in 18 µg of lysates from mouse brain. The doublet band at ~75 kDa may represent phosphorylated and non-phosphorylated forms of the protein.

Scientific Background :LIMK1 or LIM domain kinase 1 contains a unique combination of 2 N-terminal LIM domain and a C-terminal protein kinase domain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers that can bind to DNA/RNA as well as mediating protein-protein interactions (1). LIMK1 is thought to be a component of an intracellular signaling pathway that may be involved in brain development especially development of nerve cells. LIMK1 may play an important role in areas of the brain that are responsible for processing visual-spatial information (visuospatial constructive cognition). LIMK1 can regulate aspects of the cytoskeleton, the structural framework that helps to determine cell shape, size, and movement (2).

References :
1. Davila, M. et al: LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem. 2003;19;278(38):36868-75.

2. Davila, M. et al: Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer. Mol Cancer. 2007;8;6:40.

Product Sheets (By Lot #) :

B3216-55.pdf

Research Areas :Angiogenesis, Cancer, Cardiovascular Disease, Invasion/Metastasis, Ser/Thr Kinases